# SECTION 3 - 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR $\ S 8 0 7 . 9 2 ( \mathrm { c } )$ EPY

Submitted by:   
Indu Lakshman, Director of Quality & Regulatory Affairs   
BioImagene, Inc   
919 Hermosa Ct. Sunnyvale, CA 94085 United States

Date summary prepared: June, 2009   
Date summary updated: Oct, 2009

Trade Name: PATHIAMTM System with iScan for p53 and Ki-67

Classification Name: Microscope, automated, image analysis, immunohistochemistry, operator intervention, nuclear intensity & percent positivity.

# Device Description:

The PATHIAMTM System is an instrument and software system designed to assist the qualified pathologist in the consistent quantitative assessment of protein expression in immunohistochemically stained histologic sections from formalin-fixed, paraffin-embedded normal and neoplastic tissues. The system consists of a slide scanner (iScan), computer, monitor, keyboard, mouse, image analysis algorithms for specific immunohistochemical markers, and software with a Windows web browser-based user interface. PATHIAM is a web-based, end-toend digital pathology software solution that allows pathology labs to acquire, manage, view, analyze, share, and report on digital images of pathology specimens. Using the PATHIAM software, the pathologist can view digital images, add annotations, make measurements, perform image analysis, and generate reports.

Hardware: The iScan slide scanning device captures digital images of formalin-fixed, paraffin-embedded tissues that are suitable for storage and viewing. The device includes a digital slide scanner, racks for loading glass slides, computer, scanner software, keyboard, mouse and monitor.

Software: The PATHIAM software is designed to complement the routine workflow of a qualified pathologist in the review of immunohistochemically stained histologic slides. It allows the user to select fields of view (FOVs) in the digital image for analysis and provides quantitative data on these FOVs to assist with interpretation. The software makes no independent interpretations of the data and requires competent human intervention at all steps in the analysis process.

# Indications for Use:

The p53 results provided by the PATHIAM System are indicated for use en is-a-useful tool for the identification of p53 accumulation in human neoplasias when used with IVD reagents marketed for this indication. Interpretation should be made within the context of the patient's clinical history and other diagnostic tests by a qualified pathologist. The pathologist must verify agreement with the PATHIAM score.

Ki-67 results provided by the PATHIAM System are indicated for use to assess proliferative activity when used with in vitro diagnostic reagents marketed for this indication. Interpretation should be made within the context of the patient's cliniçal history and other diagnostic tests by a qualified pathologist. The pathologist must verify agreement with the PATHIAM score.

Predicate Device:   
Tripath Imaging, Inc.   
Ventana $\textcircled{8}$ Image Analysis System (VIASTM)   
K062428 - VIAS p53 application   
K053520 - VIAS Ki-67 application   
Regulation: 21 CFR $\ S 8 6 4 . 1 8 6 0$ , Immunohistochemistry Reagents and Kits Product Code: NQN   
Panel: Pathology

# Performance:

# PATHIAM System Comparison Studies (Inter and Intra Pathologist Studies)

Inter pathologist study

# Round 1 Manual Scoring:

Slides were scored by a qualified pathologist at each site manually. The three pathologists read randomly selected 120 stained tissue test samples manually on a microscope and assigned a score to each specimen (test sample) according to the scoring categories.

# Round 2 PATHIAM Assisted Scoring:

PATHIAM assisted scoring took place after a minimum of one week passed since manual slide reading. The order that the test samples were accessed (randomized) for scoring was presented to the pathologists at the time the testing was administered and was different from the order presented in Round 1 to further reduce the possibility that the manual scoring influenced the scoring using the PATHIAM system. The same three pathologists reviewed the digital images of the test samples presented by the software on the computer monitor (PATHIAM system). The pathologist had the ability to navigate freely around the images at various magnifications (as in a microscope), select field of views for scoring, and determine the score for each specimen (test sample) with the assistance of the Pathiam system according to the scoring categories.

The above two steps (Round 1 and Round 2) were performed with three investigators on the same set of test samples.

Table 1: Concordance Results for p53 Scoring   

<table><tr><td rowspan=1 colspan=1>p53 Cut-OffThreshold</td><td rowspan=1 colspan=1>Manual vs PATHIAM-assistedSubstantial EquivalenceConcordance Range for 3Pathologists</td><td rowspan=1 colspan=1>PATHIAM-assisted vsPATHIAM-assistedReproducibilityConcordance Range for3 Pathologists</td><td rowspan=1 colspan=1>Manual vs ManualReproducibilityConcordance Range for3 Pathotogists</td></tr><tr><td rowspan=1 colspan=1>&gt;1%</td><td rowspan=1 colspan=1>82% - 90%</td><td rowspan=1 colspan=1>88% - 93%</td><td rowspan=1 colspan=1>78% - 95%</td></tr><tr><td rowspan=1 colspan=1>&gt;5%</td><td rowspan=1 colspan=1>77% - 85%</td><td rowspan=1 colspan=1>90% - 93%</td><td rowspan=1 colspan=1>78% - 88%</td></tr><tr><td rowspan=1 colspan=1>&gt;10%</td><td rowspan=1 colspan=1>83% - 89%</td><td rowspan=1 colspan=1>93% - 97%</td><td rowspan=1 colspan=1>86% - 90%</td></tr></table>

Table 2: Concordance Results for Ki-67 Scoring   

<table><tr><td rowspan=1 colspan=1>Ki-67 Cut-Off Threshold</td><td rowspan=1 colspan=1>Manual vs. PATHIAM-assisted SubstantialEquivalenceConcordance Range for3 Pathologists</td><td rowspan=1 colspan=1>PATHIAM-assisted vs.PATHIAM-assistedReproducibilityConcordance Range for3 Pathologists</td><td rowspan=1 colspan=1>Manual vs. ManualReproducibilityConcordance Range for3 Pathologists</td></tr><tr><td rowspan=1 colspan=1>&gt;1%</td><td rowspan=1 colspan=1>88%-93%</td><td rowspan=1 colspan=1>92%-94%</td><td rowspan=1 colspan=1>86%-91%</td></tr><tr><td rowspan=1 colspan=1>&gt;5%</td><td rowspan=1 colspan=1>87%-93%</td><td rowspan=1 colspan=1>90%-93%</td><td rowspan=1 colspan=1>85%-89%</td></tr><tr><td rowspan=1 colspan=1>&gt;10%</td><td rowspan=1 colspan=1>81%-89%</td><td rowspan=1 colspan=1>88-95%</td><td rowspan=1 colspan=1>80%-91%</td></tr></table>

# PATHIAM System Reproducibility and Precision Study (Inter and Intra System Studies)

The intra system (PATHIAM system with iScan) study was performed on five sets of images (one set $=$ eight test samples) produced by one scanner and scored on one computer system (consisting of a computer, monitor, keyboard, p53 & Ki-67 image analysis algorithms, MS Windows web browser and a mouse). This study was repeated on a total of three different scanners and computer systems. Test samples were pre-selected (field of views) by a qualified pathologist. See the data analysis tables below.

# p53 System Study Precision (between run) Results:

Table 5: Intra-system Precision Study - System I for p53   

<table><tr><td rowspan=1 colspan=1>Sample ID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>A7</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>:</td></tr><tr><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>C9</td><td rowspan=1 colspan=1>42.90</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.06</td></tr><tr><td rowspan=1 colspan=1>B5</td><td rowspan=1 colspan=1>2.82</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>2.67</td></tr><tr><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>73.50</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.07</td></tr><tr><td rowspan=1 colspan=1>B9</td><td rowspan=1 colspan=1>16.44</td><td rowspan=1 colspan=1>0.01</td><td rowspan=1 colspan=1>0.09</td></tr><tr><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>22.14</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>0.32</td></tr><tr><td rowspan=1 colspan=1>B3</td><td rowspan=1 colspan=1>24.05</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.23</td></tr></table>

(S=u) t wasAs

Table 6: Intra system Precision Study  System I or p53   

<table><tr><td rowspan=1 colspan=1>Sample ID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>A7</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>:</td></tr><tr><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>:</td></tr><tr><td rowspan=1 colspan=1>C9</td><td rowspan=1 colspan=1>42.74</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.05</td></tr><tr><td rowspan=1 colspan=1>B5</td><td rowspan=1 colspan=1>2.57</td><td rowspan=1 colspan=1>0.01</td><td rowspan=1 colspan=1>0.58</td></tr><tr><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>72.89</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.06</td></tr><tr><td rowspan=1 colspan=1>B9</td><td rowspan=1 colspan=1>16.51</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.24</td></tr><tr><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>22.44</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.17</td></tr><tr><td rowspan=1 colspan=1>B3</td><td rowspan=1 colspan=1>22.68</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.25</td></tr></table>

Table 7: Intra system Precision Study - System III for p53   

<table><tr><td rowspan=1 colspan=1>Sample ID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>A7</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>:</td></tr><tr><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>:</td></tr><tr><td rowspan=1 colspan=1>C9</td><td rowspan=1 colspan=1>42.60</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.11</td></tr><tr><td rowspan=1 colspan=1>B5</td><td rowspan=1 colspan=1>2.71</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.78</td></tr><tr><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>74.07</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>0.18</td></tr><tr><td rowspan=1 colspan=1>B9</td><td rowspan=1 colspan=1>16.49</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.18</td></tr><tr><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>24.42</td><td rowspan=1 colspan=1>0.01</td><td rowspan=1 colspan=1>0.05</td></tr><tr><td rowspan=1 colspan=1>B3</td><td rowspan=1 colspan=1>24.90</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>0.40</td></tr></table>

(=) ε wss

# Ki-67 System Study Precision (between run) Results:

Table 8: Intra system Precision Study - System I for Ki-67   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>SampleID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=8 colspan=1> A os La(S=u) t wasAs</td><td rowspan=1 colspan=1>A2</td><td rowspan=1 colspan=1>31.78</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>0.31</td></tr><tr><td rowspan=1 colspan=1>E2</td><td rowspan=1 colspan=1>64.53</td><td rowspan=1 colspan=1>0.25</td><td rowspan=1 colspan=1>0.39</td></tr><tr><td rowspan=1 colspan=1>A3</td><td rowspan=1 colspan=1>15.45</td><td rowspan=1 colspan=1>0.15</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>17.82</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.50</td></tr><tr><td rowspan=1 colspan=1>E7</td><td rowspan=1 colspan=1>9.76</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.22</td></tr><tr><td rowspan=1 colspan=1>D6</td><td rowspan=1 colspan=1>4.85</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.40</td></tr><tr><td rowspan=1 colspan=1>E5</td><td rowspan=1 colspan=1>9.13</td><td rowspan=1 colspan=1>0.12</td><td rowspan=1 colspan=1>1.35</td></tr><tr><td rowspan=1 colspan=1>A1</td><td rowspan=1 colspan=1>0.88</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>1.78</td></tr></table>

Table 9: Intra system Precision Study - System II for Ki-67   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>SampleID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=8 colspan=1>Z    od ∠M</td><td rowspan=1 colspan=1>A2</td><td rowspan=1 colspan=1>32.77</td><td rowspan=1 colspan=1>0.37</td><td rowspan=1 colspan=1>1.13</td></tr><tr><td rowspan=1 colspan=1>E2</td><td rowspan=1 colspan=1>63.29</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>0.12</td></tr><tr><td rowspan=1 colspan=1>A3</td><td rowspan=1 colspan=1>15.76</td><td rowspan=1 colspan=1>0.17</td><td rowspan=1 colspan=1>1.09</td></tr><tr><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>17.91</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.23</td></tr><tr><td rowspan=1 colspan=1>E7</td><td rowspan=1 colspan=1>9.41</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.44</td></tr><tr><td rowspan=1 colspan=1>D6</td><td rowspan=1 colspan=1>4.87</td><td rowspan=1 colspan=1>0.14</td><td rowspan=1 colspan=1>2.90</td></tr><tr><td rowspan=1 colspan=1>E5</td><td rowspan=1 colspan=1>9.27</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.42</td></tr><tr><td rowspan=1 colspan=1>A1</td><td rowspan=1 colspan=1>0.85</td><td rowspan=1 colspan=1>0.01</td><td rowspan=1 colspan=1>0.89</td></tr></table>

Table 10: Intra system Precision Study - System III for Ki-67   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>SampleID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=6 colspan=1>E   A od M</td><td rowspan=1 colspan=1>A2</td><td rowspan=1 colspan=1>31.53</td><td rowspan=1 colspan=1>0.19</td><td rowspan=1 colspan=1>0.59</td></tr><tr><td rowspan=1 colspan=1>E2</td><td rowspan=1 colspan=1>62.11</td><td rowspan=1 colspan=1>0.23</td><td rowspan=1 colspan=1>0.36</td></tr><tr><td rowspan=1 colspan=1>A3</td><td rowspan=1 colspan=1>15.05</td><td rowspan=1 colspan=1>0.12</td><td rowspan=1 colspan=1>0.78</td></tr><tr><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>17.66</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.14</td></tr><tr><td rowspan=1 colspan=1>E7</td><td rowspan=1 colspan=1>9.81</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>0.72</td></tr><tr><td rowspan=1 colspan=1>D6</td><td rowspan=1 colspan=1>4.95</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.68</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>E5</td><td rowspan=1 colspan=1>9.43</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.24</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>A1</td><td rowspan=1 colspan=1>0.86</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.35</td></tr></table>

# Reproducibility (between Run/Inter System) Study

The data from the above three intra-system studies were used to understand the inter-system comparison.

Table 11: Inter system Reproducibility Study - p53   

<table><tr><td rowspan=1 colspan=1>SampleID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>A7</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>:</td></tr><tr><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>b</td></tr><tr><td rowspan=1 colspan=1>C9</td><td rowspan=1 colspan=1>42.75</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>0.30</td></tr><tr><td rowspan=1 colspan=1>B5</td><td rowspan=1 colspan=1>2.70</td><td rowspan=1 colspan=1>0.12</td><td rowspan=1 colspan=1>4.32</td></tr><tr><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>73.49</td><td rowspan=1 colspan=1>0.50</td><td rowspan=1 colspan=1>0.68</td></tr><tr><td rowspan=1 colspan=1>B9</td><td rowspan=1 colspan=1>16.48</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.25</td></tr><tr><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>23.00</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=1>4.55</td></tr><tr><td rowspan=1 colspan=1>B3</td><td rowspan=1 colspan=1>23.88</td><td rowspan=1 colspan=1>0.95</td><td rowspan=1 colspan=1>3.97</td></tr></table>

(3^t-u)

Table 12: Inter system Reproducibility Study - Ki67   

<table><tr><td rowspan=1 colspan=1>LineItem #</td><td rowspan=1 colspan=1>SampleID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>A2</td><td rowspan=1 colspan=1>32.03</td><td rowspan=1 colspan=1>0.60</td><td rowspan=1 colspan=1>1.87</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E2</td><td rowspan=1 colspan=1>63.31</td><td rowspan=1 colspan=1>1.04</td><td rowspan=1 colspan=1>1.65</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>A3</td><td rowspan=1 colspan=1>15.42</td><td rowspan=1 colspan=1>0.33</td><td rowspan=1 colspan=1>2.14</td></tr><tr><td rowspan=1 colspan=1>TMA 42007</td><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>17.79</td><td rowspan=1 colspan=1>0.12</td><td rowspan=1 colspan=1>0.66</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E7</td><td rowspan=1 colspan=1>9.66</td><td rowspan=1 colspan=1>0.19</td><td rowspan=1 colspan=1>1.95</td></tr><tr><td rowspan=1 colspan=1>TMA 52007</td><td rowspan=1 colspan=1>D6</td><td rowspan=1 colspan=1>4.89</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>1.84</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E5</td><td rowspan=1 colspan=1>9.28</td><td rowspan=1 colspan=1>0.14</td><td rowspan=1 colspan=1>1.53</td></tr><tr><td rowspan=1 colspan=1>TMA 22007</td><td rowspan=1 colspan=1>A1</td><td rowspan=1 colspan=1>0.86</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>2.07</td></tr></table>

(Sε=) ε 'Z 't wasAs

# Substantial Equivalence

Table 13: Comparison to Predicate Devices to Support Substantial Equivalence Determination for p53 Image Analysis Systems   

<table><tr><td>Attribute</td><td>PATHIAM System for p53</td><td>Tripath (VIAS p53) K062428</td></tr><tr><td rowspan="2">Intended Use</td><td rowspan="2">This device is intended for in vitro diagnostic (IVD) use. The PATHIAM System is intended as an aid to the pathologist to detect, count, and classify cells of clinical interest based on recognition of cellular objects of particular color, size, and shape, using appropriate</td><td>This antibody is intended for in vitro diagnostic (IVD) use. Ventana® Medical Systems</td></tr><tr><td>(Ventana) CONFIRM anti-p53 (DO- primary antibody is a mouse monoclonal antibody (IgG1, kappa) directed against human p53. The antibody is intended for laboratory use to qualitatively identify by light microscopy wild type and mutant p53 in sections of formalin fixed,</td></tr><tr><td colspan="1" rowspan="1">Attribute</td><td colspan="1" rowspan="1">PATHIAM System for p53</td><td colspan="1" rowspan="1">Tripath (VIAS p53)K062428</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">use as an aid to the pathologist toquantify the percentage of positivelystained nuclei in formalin fixedparaffin embedded breast tissuespecimens stained with Dako mousemonoclonal anti-human p53antibody, clone DO7and visualizedwith DAB chromogen, to detect bothwild-type and mutant p53, a nuclearprotein, as specified in theinstructions for these reagents. It isthe responsibility of a qualifiedpathologist to employ appropriatemorphological studies and controlsas specified in the instructions forDako p53 to assure the validity ofthe PATHIAM-assisted p53assessment.</td><td colspan="1" rowspan="1">paraffin embedded tissue on aVentana automated slide stainer.</td></tr><tr><td colspan="1" rowspan="1">Indications foruse</td><td colspan="1" rowspan="1">The p53 results provided by thePATHIAM System are indicated foruse for the identification of p53accumulation in human neoplasiaswhen used with IVD reagentsmarketed for this indication.Interpretation should be made withinthe context of the patient's clinicalhistory and other diagnostic tests bya qualified pathologist. Thepathologist must verify agreementwith the PATHIAM score.</td><td colspan="1" rowspan="1">The Ventana Image AnalysisSystem (VIASTM) is an adjunctivecomputer-assisted image analysissystem functionally connected to aninteractive microscope. It is intendedfor use as an aid to the pathologist inthe detection, classification andcounting of cells of interest 2 basedon marker intensity, size and shapeusing appropriate controls to assurethe validityof the VIAS scores.</td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Formalin-fixed, paraffin embeddedbreast cancer specimens stained byimmunohistochemistry reagent forp53</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Image AnalysisSystem</td><td colspan="1" rowspan="1">Histologic observation by apathologist through theBioImagene's PATHIAM imageanalysis system with iScan slidescanner.</td><td colspan="1" rowspan="1">Histologic observation by apathologist through a specifiedinteractive microscope/digitalcamera with image analysissoftware.</td></tr><tr><td colspan="1" rowspan="1">Hardware andSoftware</td><td colspan="1" rowspan="1">PATHIAM software, BioImageneiScan slide scanner, computer,</td><td colspan="1" rowspan="1">VIAS with software, computer,microscope, motorized stage, digital</td></tr><tr><td colspan="1" rowspan="1">Components</td><td colspan="1" rowspan="1">mouse, keyboard, windows webbrowser and monitor.</td><td colspan="1" rowspan="1">color video camera, mouse,keyboard, and monitor.</td></tr><tr><td colspan="1" rowspan="1">Assay used</td><td colspan="1" rowspan="1">The tissues were stained using theDako p53, clone DO7TM monoclonalantibody.</td><td colspan="1" rowspan="1">Ventana Confirm™M anti-p53 (DO-7)</td></tr></table>

Table 14: Comparison to Predicate Devices to Support Substantial Equivalence Determination for Ki-67 Image Analysis Systems   

<table><tr><td colspan="1" rowspan="1">Attribute</td><td colspan="1" rowspan="1">PATHIAM System for Ki-67</td><td colspan="1" rowspan="1">Tripath (VIAS Ki-67)K053520</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">This device is intended for in vitrodiagnostic (IVD) use.The PATHIAM System is intendedas an aid to the pathologist to detect,count, and classify cells of clinicalinterest based on recognition ofcellular objects of particular color,size, and shape, using appropriatecontrols to assure the validity of thescores.The Ki-67 application is intended asan aid to the pathologist to quantifythe percentage of positively stainednuclei in formalin-fixed paraffinembedded normal and neoplasticbreast tissue specimensimmunohistochemically stained withDako mouse monoclonal anti-humanKi-67 antigen, clone MIB1visualized with DAB chromogen asspecified in the instructions for thesereagents. It is the responsibility of aqualified pathologist to employappropriate morphological studiesand controls as specified in theinstructions for Dako Ki-67 toassure the validity of the</td><td colspan="1" rowspan="1">This device is intended for in vitrodiagnostic (IVD) use.The Ventana Image AnalysisSystem (VIAS) is an adjunctivecomputer-assisted imageanalysis system functionallyconnected to an interactivemicroscope. It is intended foruse as an aid to the pathologist in thedetection, classification andcounting of cells of interest based onmarker intensity, size and shapeusing appropriate controls to assurethe validity of the VIAS scores.In this application, the VIAS isintended to aid a qualifiedpathologist in the acquisitionand measurement of images toquantify the percentage of positivelystained nuclei in paraffin embeddedbreast cancer tissue specimensimmunohistochemically stained forthe presence of Ki-67 proteins usingVentana's reagents and nuclearhematoxylin. It is indicated for usein assessing the proliferative activityof normal and neoplastic breasttissue when used with in vitro</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">PATHIAM-assisted Ki-67assessment.</td><td colspan="1" rowspan="1">diagnostic reagents marketed forthese indications.</td></tr><tr><td colspan="1" rowspan="1">Indications foruse</td><td colspan="1" rowspan="1">Ki-67 results provided by thePATHIAM System are indicated foruse to assess proliferative activitywhen used with in vitro diagnosticreagents marketed for thisindication. Interpretation should bemade within the context of thepatient's clinical history and otherdiagnostic tests by a qualifiedpathologist. The pathologist mustverify agreement with thePATHIAM score.</td><td colspan="1" rowspan="1">It is indicated for use in assessingthe proliferative activity of normaland neoplastic breast tissue whenused with in vitro diagnosticreagents marketed for theseindications</td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Formalin-fixed, paraffin embeddedspecimens stained byimmunohistochemistry reagent forKi-67</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Image AnalysisSystem</td><td colspan="1" rowspan="1">Histologic observation by apathologist through theBioImagene's PATHIAM imageanalysis system with/ iScan slidescanner.</td><td colspan="1" rowspan="1">Histologic observation by apathologist through a specifiedinteractive microscope/digitalcamera with image analysissoftware.</td></tr><tr><td colspan="1" rowspan="1">Hardware andSoftwareComponents</td><td colspan="1" rowspan="1">PATHIAM software, BioImageneiScan slide scanner, computer,mouse, keyboard, windows webbrowser and monitor.</td><td colspan="1" rowspan="1">VIAS with software, computer,microscope, motorized stage, digitalcolor video camera, mouse,keyboard, and monitor.</td></tr><tr><td colspan="1" rowspan="1">Assay used</td><td colspan="1" rowspan="1">The tissues were stained using DakoKi-67, clone MIB1 antibody.</td><td colspan="1" rowspan="1">Per Ventana Ki-67 kit product insert(Catalogue Number 790-2910)</td></tr></table>

Standards Employed None under Section 514

FDA Guidance Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices, May 11, 2005

# General Description

The PATHIAM™M System is an instrument and software system designed to assist the qualified pathologist in the consistent quantitative assessment of protein expression in immunohistochemically stained histologic sections from formalin-fixed, paraffin-embedded normal and neoplastic tissues. The system consists of a slide scanner (iScan), computer, monitor, keyboard, mouse, image analysis algorithms for specific immunohistochemical markers, and software with a Windows web browser-based user interface. PATHIAM is a web-based, end-toend digital pathology software solution that allows pathology labs to acquire, manage, view, analyze, share, and report on digital images of pathology specimens. Using the PATHIAM software, the pathologist can view digital images, add annotations, make measurements, perform image analysis, and generate reports.

Hardware: The iScan slide scanning device captures digital images of formalin-fixed, paraffin-embedded tissues that are suitable for storage and viewing. The device includes a digital slide scanner, racks for loading glass slides, computer, scanner software, keyboard, mouse and monitor.

Software: The PATHIAM software is designed to complement the routine workflow of a qualified pathologist in the review of immunohistochemically stained histologic slides. It allows the user to select fields of view (FOVs) in the digital image for analysis and provides quantitative data on these FOVs to assist with interpretation. The software makes no independent interpretations of the data and requires competent human intervention at all steps in the analysis process.

Additional materials required:

• Dako p53, clone $\mathbf { D 0 7 ^ { T M } }$ monoclonal antibody Dako Ki-67, clone MIB 1 monoclonal antibody Reagents for visualization, such as DAB chromagen Associated materials for completing immunohistochemical staining according to the appropriate package insert Color printer if user wishes to print out color copies

# Device Quality Control

The quality of results depends on the laboratory following the quality control instructions recommended in the labeling of the immunohistochemistry (IHC) reagents. The software also performs a quality check on the digital images to determine if they are suitable for further analysis using "Image Quality Assessment" algorithms.

# Summary of Procedure

Samples are obtained as formalin-fixed, paraffin-embedded tissue blocks. Histologic sections are prepared and mounted onto glass slides. Slides are reacted with either Ki-67 or p53 primary antibodies. Slides are visualized using DAB. Prepared slides are loaded into the PATHIAM system scanner and scanned. The resulting digital images are reviewed by the pathologist on a computer monitor, and appropriate fields of view (FOVs) are then selected for analysis by the PATHIAM software. The PATHIAM software produces a "percent positive" result for the specific immunohistochemical study (Ki-67 or p53), and the pathologist has the choice of accepting the result or entering his/her own score.

# Principal of Operation

After the initial image quality check, the algorithm goes through the following steps before generating the analysis results:

1. Field of View (FOV) identification: The algorithm separates the tissue area from the background such that only the tissue area is processed in the following steps.   
2. Preprocessing: The algorithm generates two images after preprocessing. One of them is a contrast stretched image, and the other is an image with each of the tissue AOI pixels classified as stained or non-stained.   
3. Segmentation: This processing step consists of extracting the objects of interest from the image. In the current applications, the objects of interest are epithelial cell nuclei. These are separated out from the rest of the identified objects using morphological properties, such as size and shape.   
4. Classification: The segmented nuclei are classified as stained cells or non-stained cells based on the percentage of stained pixels within them.   
5. Scoring / Grading: Based on the classification, an overall score for the image is computed using the numbers of stained cells, non-stained cells and total cells for the calculations.

Table 15 - BioImagene iScan Slide Scanner Specifications   

<table><tr><td rowspan=1 colspan=1>Input Format</td><td rowspan=1 colspan=1>1 x 3 inch (25 x 75mm) microscope slides</td></tr><tr><td rowspan=1 colspan=1>Slide Capacity</td><td rowspan=1 colspan=1>1 to 160 slides using 8 integrated standardSakura racks</td></tr><tr><td rowspan=1 colspan=1>Microscope Objective</td><td rowspan=1 colspan=1>Olympus 20x/0.50 Plan Fluor (Nikon 20x/0.50Plan Fluor)</td></tr><tr><td rowspan=1 colspan=1>Scanning Resolution</td><td rowspan=1 colspan=1>0.46 μm/pixel @ 20x</td></tr><tr><td rowspan=1 colspan=1>Camera Frame Size</td><td rowspan=1 colspan=1>1392x1032</td></tr><tr><td rowspan=1 colspan=1>Light Source (Illumination)</td><td rowspan=1 colspan=1>Integrated LED</td></tr><tr><td rowspan=1 colspan=1>Auto-Scan</td><td rowspan=1 colspan=1>Automated barcode reading, tissueidentification, autofocus, scanning and JPEG2000 compression for up to 160 slides</td></tr><tr><td rowspan=1 colspan=1>Manual Scan</td><td rowspan=1 colspan=1>User selects scan area for single or batchedslides in automatic or manual mode</td></tr><tr><td rowspan=1 colspan=1>Throughput</td><td rowspan=1 colspan=1>~ 4 minutes/slide in batch mode (15 x 15mmscan area @ 20x)- Time To View (defined as total pre-processing time, scanning time and encodingtime)</td></tr><tr><td rowspan=1 colspan=1>Scan Viewing</td><td rowspan=1 colspan=1>24-bit true color</td></tr><tr><td rowspan=1 colspan=1>Slide Storage Format</td><td rowspan=1 colspan=1>JPEG 2000</td></tr><tr><td rowspan=1 colspan=1>Compression</td><td rowspan=1 colspan=1>1:1-20:1 (range)</td></tr><tr><td rowspan=1 colspan=1>Barcode Capability</td><td rowspan=1 colspan=1>1D and 2D option</td></tr><tr><td rowspan=1 colspan=1>Dimensions</td><td rowspan=1 colspan=1>Approximately 18 x 18 x 17 high inches (45 x45 x 41 high mm)</td></tr><tr><td rowspan=1 colspan=1>Weight</td><td rowspan=1 colspan=1>75 lbs (23 kg)</td></tr><tr><td rowspan=1 colspan=1>Power</td><td rowspan=1 colspan=1>110-240 VAC, 50/60 Hz</td></tr></table>

Table 16: Comparison to Predicate Devices to Support Substantial Equivalence Determination   

<table><tr><td rowspan=1 colspan=1>Attribute</td><td rowspan=1 colspan=1>PATHIAM System</td><td rowspan=1 colspan=1>Tripath (VIAS p53)K062428</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>This device is intended for in vitrodiagnostic (IVD) use.The PATHIAM System is intendedas an aid to the pathologist todetect, count, and classify cells ofclinical interest based onrecognition of cellular objects ofparticular color, size, and shape,using appropriate controls to assurethe validity of the scores.The p53 application is intended foruse as an aid to the pathologist toquantify the percentage ofpositively stained nuclei informalin fixed paraffin embeddedbreast tissue specimens stainedwith Dako mouse monoclonal anti-human p53 antibody, cloneDO7and visualized with DABchromogen, to detect both wild-type and mutant p53, a nuclearprotein, as specified in theinstructions for these reagents. Itis the responsibility of a qualifiedpathologist to employ appropriatemorphological studies and controlsas specified in the instructions forDako p53 to assure the validity ofthe PATHIAM-assisted p53assessment.</td><td rowspan=1 colspan=1>This antibody is intended forin vitro diagnostic (IVD) use.Ventana® Medical Systems(Ventana) CONFIRM anti-p53 (DO-7) primary antibodyis a mouse monoclonalantibody (IgGl, kappa)directed against human p53.The antibody is intended forlaboratory use to qualitativelyidentify by light microscopywild type and mutant p53 insections of formalin fixed,paraffin embedded tissue on aVentana automated slidestainer.</td></tr><tr><td rowspan=2 colspan=1>Indications for use</td><td rowspan=2 colspan=1>The p53 results provided by thePATHIAM System are indicatedfor use for the identification of p53accumulation in human neoplasias</td><td rowspan=1 colspan=1>The Ventana Image AnalysisSystem (VIASTM) is anadjunctive computer-assistedimage analysis system</td></tr><tr><td></td></tr></table>

Table 17: Comparison to Predicate Devices to Support Substantial Equivalence Determination   

<table><tr><td rowspan=1 colspan=1>Attribute</td><td rowspan=1 colspan=1>PATHIAM System</td><td rowspan=1 colspan=1>Tripath (VIAS p53)K062428</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>when used with IVD reagentsmarketed for this indication.Interpretation should be madewithin the context of the patient&#x27;sclinical history and otherdiagnostic tests by a qualifiedpathologist. The pathologist mustverify agreement with thePATHIAM score.</td><td rowspan=1 colspan=1>functionally connected to aninteractive microscope. It isintended for use as an aid tothe pathologist in thedetection, classification andcounting of cells of interestbased on marker intensity,size and shape usingappropriate controls to assurethe validity of the VIASscores.</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Formalin-fixed, paraffin embeddedbreast cancer specimens stained byimmunohistochemistry reagent forp53</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Image AnalysisSystem</td><td rowspan=1 colspan=1>Histologic observation by apathologist through BioImagene&#x27;sPATHIAM image analysis systemwith iScan slide scanner.</td><td rowspan=1 colspan=1>Histologic observation by apathologist through aspecified interactivemicroscope/digital camerawith image analysis software.</td></tr><tr><td rowspan=1 colspan=1>Hardware andSoftwareComponents</td><td rowspan=1 colspan=1>PATHIAM software, BioImageneiScan slide scanner, computer,mouse, keyboard, windows webbrowser and monitor.</td><td rowspan=1 colspan=1>VIAS with software,computer, microscope,motorized stage, digital colorvideo camera, mouse,keyboard, and monitor.</td></tr><tr><td rowspan=1 colspan=1>Assay used</td><td rowspan=1 colspan=1>Dako p53, clone DO7TMmonoclonal antibody</td><td rowspan=1 colspan=1>Ventana ConfirmT anti-p53(DO-7)</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Attribute</td><td colspan="1" rowspan="1">PATHIAM System</td><td colspan="1" rowspan="1">Tripath (VIAS Ki-67)K053520</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">This device is intended for invitro diagnostic (IVD) use.The PATHIAM System isintended as an aid to thepathologist to detect, count, andclassify cells of clinical interestbased on recognition of cellularobjects of particular color, size,and shape, using appropriatecontrols to assure the validity of</td><td colspan="1" rowspan="1">This device is intended for invitro diagnostic (IVD) use.The Ventana Image AnalysisSystem (VIAS) is an adjunctivecomputer-assisted imageanalysis system functionallyconnected to an interactivemicroscope. It is intended foruse as an aid to the pathologist inthe detection, classification and</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">the scores.The Ki-67 application is intendedas an aid to the pathologist toquantify the percentage ofpositively stained nuclei informalin-fixed paraffin embeddednormal and neoplastic breasttissue specimensimmunohistochemically stainedwith Dako mouse monoclonalanti-human Ki-67 antigen,clone MIB1 visualized with DABchromogen as specified in theinstructions for these reagents. Itis the responsibility of a qualifiedpathologist to employ appropriatemorphological studies andcontrols as specified in theinstructions for Dako Ki-67 toassure the validity of thePATHIAM-assisted Ki-67assessment.</td><td colspan="1" rowspan="1">counting of cells of interest basedon marker intensity, size andshape using appropriate controlsto assure the validity of the VIASscores.In this application, the VIAS isintended to aid a qualifiedpathologist in the acquisitionand measurement of images toquantify the percentage ofpositively stained nuclei inparaffin embedded breast cancertissue specimensimmunohistochemically stainedfor the presence of Ki-67 proteinsusing Ventana's reagents andnuclear hematoxylin. It isindicated for use in assessing theproliferative activity of normaland neoplastic breasttissue when used with in vitrodiagnostic reagents marketed forthese indications.</td></tr><tr><td colspan="1" rowspan="1">Indications foruse</td><td colspan="1" rowspan="1">Ki-67 results provided by thePATHIAM System are indicatedfor use to assess proliferativeactivity when used with in vitrodiagnostic reagents marketed forthis indication. Interpretationshould be made within thecontext of the patient's clinicalhistory and other diagnostic testsby a qualified pathologist. Thepathologist must verifyagreement with the PATHIAMscore.</td><td colspan="1" rowspan="1">It is indicated for use in assessingthe proliferative activity ofnormal and neoplastic breasttissue when used with in vitrodiagnostic reagents marketed forthese indications</td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Formalin-fixed, paraffinembedded specimens stained byimmunohistochemistry reagentfor Ki-67</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Image AnalysisSystem</td><td colspan="1" rowspan="1">Histologic observation by apathologist throughBioImagene's PATHIAM image</td><td colspan="1" rowspan="1">Histologic observation by apathologist through a specifiedinteractive microscope/digital</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">analysis system with iScan slidescanner.</td><td colspan="1" rowspan="1">camera with image analysissoftware.</td></tr><tr><td colspan="1" rowspan="1">Hardware andSoftwareComponents</td><td colspan="1" rowspan="1">PATHIAM software, BioImageneiScan slide scanner, computer,mouse, keyboard, windows webbrowser and monitor.</td><td colspan="1" rowspan="1">VIAS with software, computer,microscope, motorized stage,digital color video camera,mouse, keyboard, and monitor.</td></tr><tr><td colspan="1" rowspan="1">Assay used</td><td colspan="1" rowspan="1">Dako Ki-67, clone MIB1monoclonal antibody.</td><td colspan="1" rowspan="1">Per Ventana Ki-67 kit productinsert (Catalogue Number 790-2910)</td></tr></table>

# Substantial Equivalence Conclusion

Substantial equivalence is demonstrated by identical intended use and similar performance. The technological differences between the device and the predicate do not raise new questions or concerns of safety and effectiveness.

# Volume 1 Page 33

# Volume 1 Page 34

# PATHIAM System Comparison Studies (inter and intra pathologist)

Title: Performance of the PATHIAM System for analysis of p53 and Ki-67 nuclear protein immunohistochemistry in breast tissue.

# Objective:

The objectives of the study were two-fold:

1. To compare the performance of the PATHIAM system to manual microscopy for the assessment of Ki67 & p53 immunohistochemistry.

To determine whether inter-pathologist and intra-pathologist scoring of Ki67 & p53 immunohistochemistry using the PATHIAM system is reproducible.

Protocol Number: TP-000046 Rev. B

# Device Description:

The PATHIAMTM System is an instrument and software system designed to assist the qualified pathologist in the consistent quantitative assessment of protein expression in immunohistochemically stained histologic sections from formalin-fixed, paraffinembedded normal and neoplastic tissues. The system consists of a slide scanner (iScan), computer, monitor, keyboard, mouse, image analysis algorithms for specific immunohistochemical markers, and software with a Windows web browser-based user interface. PATHIAM is a web-based, end-to-end digital pathology software solution that allows pathology labs to acquire, manage, view, analyze, share, and report on digital images of pathology specimens. Using the PATHIAM software, the pathologist can view digital images at various magnifications, add annotations, make measurements, perform image analysis, and generate reports.

Predicates: K053520, K062428

Investigators:   
Gist Farr, MD, Spartanburg, SC   
Lynn Goldstein, MD, PhenoPath Laboratories, Seattle, WA Beiru Chen, MD, Delta Pathology Associates, Stockton, CA

Investigator Training: Investigators received training prior to participation in the study. Training included a review of the protocol, good clinical practice, detailed manual scoring instructions, case report form completion, study timelines, and a microscope session that included a reference slide review, use of the sample list, TMA map, and low power print outs.

Immediately prior to the second round of scoring using the PATHIAM system, a second training was conducted that included a review of a PATHIAM Scoring Presentation, detailed PATHIAM Scoring Instructions and a computer session that consisted of reference slide review, use of the sample list, and assisted scoring with the PATHIAM Software.

Sample Procurement Center:   
Ohio State University Medical Center   
310 Doan Hall, 410 West $1 0 ^ { \mathfrak { t h } }$ Av, Columbus, OH   
CLIA # 36D1046162

# Tissue Procurement, Preparation and Staining:

Procurement and slide preparation was under the direction of Dr. Sanford H. Barsky, Chair, Department of Pathology, Ohio State University School of Medicine (OSU). Tissues were acquired from select patient material in the form of archived pathological specimens stored as either paraffin blocks or previously made Tissue Micro Arrays (TMAs). 188 formalin fixed paraffin blocks of breast cancer samples from different patients were used to prepare five tissue micro-arrays (TMAs). Individual TMA cores measured $2 \mathrm { m m }$ in diameter. Sections from each block were prepared at OSU and mounted onto glass slides.

The slides were stained for the identification of Ki67 protein using Dako clone MIB1 monoclonal antibody and DAB detection and for the identification of p53 protein using Dako clone ${ \bf D O 7 ^ { T M } }$ monoclonal antibody and DAB detection.

# Comparative Study Investigators:

Gist Farr, MD, Spartanburg, SC Lynn Goldstein, MD, PhenoPath Laboratories, Seattle, WA Beiru Chen, MD, Delta Pathology Associates, Stockton, CA

Study Locations:   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Manual Scoring</td><td rowspan=1 colspan=1>PATHIAM Scoring</td></tr><tr><td rowspan=1 colspan=1>Dr. Farr::</td><td rowspan=1 colspan=1>Unlversity of Puget SoundBiology Dept.1500 North Wamer St.Tacoma, WA 98416</td><td rowspan=1 colspan=1>Sound Clinlcal Research, LLC3519 N Adams StTacoma, WA 98407</td></tr><tr><td rowspan=1 colspan=1>Dr. Chen</td><td rowspan=1 colspan=1>Division of Pathology and Lab MedicirieDoctors Hospital1205 E North St.Manteca, CA 95336</td><td rowspan=1 colspan=1>Biolmagene, Inc.919 Hermosa CourtSunnyvale, CA 94085</td></tr><tr><td rowspan=1 colspan=1>Dr. Goldstein</td><td rowspan=1 colspan=1>PhenoPath Laboratories551 North 34th Street. Sunte 100Seattle, Washington 98103</td><td rowspan=1 colspan=1>PhenoPath Laboratories551 North 34th Street, Suite 100Seattle. Washington 98103</td></tr></table>

IRBs:   
For the Use of Tissue:   
Ohio State University   
Office of Responsible Research Practices   
300 Research Foundation   
1960 Kenny Road   
Columbus, OH 43210-1063   
For the Study Protocol and Investigators:   
Aspire IRB   
9320 Fuerte Drive, Suite 105   
La Mesa, CA 91941

# Study Design

The Ki67study involved three investigators (qualified pathologists) affiliated with different clinical labs utilizing 120 de-identified archived breast carcinoma sections in TMA form, stained for the identification of Ki67 protein using Dako clone MIB1 monoclonal antibody and DAB detection. Samples spanned a range of positivity from 0 (negative) to $100 \%$ . The slides (test samples) required for the study were scanned by BioImagene.

The p53 study involved three investigators (qualified pathologists) affiliated with 'different clinical labs utilizing 120 de-identified archived breast carcinoma sections in TMA form, stained for the identification of p53 protein using Dako clone DO7TM monoclonal antibody and DAB detection. Samples spanned a range of positivity from 0 (negative) to $100 \%$ . The slides (test samples) required for the study were scanned by BioImagene.

System & Input Requirements for PATHIAM System   

<table><tr><td colspan="1" rowspan="1">Application</td><td colspan="1" rowspan="1">Computer Analysis of Digitized Image</td></tr><tr><td colspan="1" rowspan="1">SystemRequirements</td><td colspan="1" rowspan="1">iScan scannerComputer, MonitorPATHIAM Software</td></tr><tr><td colspan="1" rowspan="1">System Input</td><td colspan="1" rowspan="1">Microscope slides to scanner</td></tr><tr><td colspan="1" rowspan="1">Pathologist Input</td><td colspan="1" rowspan="1">Select image to load from scannerSelect test samplesScore test sample under microscopeChoose FOVs from each test sampleClick ANALYZE button</td></tr><tr><td></td><td>Review PATHIAM Score Accept PATHIAM score or Enter own score (PATHIAM- assisted)</td></tr></table>

# Inter pathologist study

# Round 1 Manual Scoring:

Slides were scored by a qualified pathologist at each site manually. The three pathologists individually reviewed 120 tissue samples immunohistochemically stained for p53 or Ki67 on a microscope and assigned a score to each specimen (test sample) according to the scoring categories.

# Round 2 PATHIAM Assisted Scoring:

PATHIAM assisted scoring took place after a minimum of one week passed since manual slide reading. The order that the test samples were accessed (randomized) for scoring was presented to the pathologists at the time the testing was administered and was different from the order presented in Round 1 to further reduce the possibility that the manual scoring influenced the scoring using the PATHIAM system. The same three pathologists reviewed the digital images of the test samples presented by the software on a computer monitor (PATHIAM system). The pathologists had the ability to navigate freely around the images at various magnifications (as in a microscope), select fields of views for scoring, and determine the score for each specimen (test sample) with the assistance of the PATHIAM system according to the scoring categories.

The above two steps (Round 1 and Round 2) were performed with three investigators on the same set of test samples.

# Intra pathologist study

A single pathologist scored 20 of the 120 tissue samples for both for p53 and Ki67 (five samples randomly chosen from each scoring category) two additional times using the same PATHIAM system. Between reads, the pathologist was given a wash-out period of at least 3 days, and the samples were randomly presented each time (to further support wash-out and blinding) to the pathologist in all scoring sessions.

# Test Samples for p53 Study:

Samples were sourced from a single research center, Ohio State University Medical Center (OSU), under IRB oversight and approval. 188 unique archived de-identified invasive breast carcinoma tissue specimens were used to create five TMAs. Sections of the TMAs were stained for p53 by OSU. Individual TMA cores measured 2 mm in diameter, with the total area of tissue for evaluation in each core equivalent to 16 high-power fields of view (400x magnification). The TMA slide set was scored by a qualified pathologist from BioImagene, at which time TMA cores with insufficient tissue/tumor for evaluation and/or artifacts that obscured tissue assessment were excluded. The remainder of the cores (160) were placed into one of four positivity categories: 0-1% (57), >1-5% (24), >5-10% (26) and >10% (53).

The study sample set utilized 120 total TMA cores spanning a range of positivity from 0 to $100 \%$ . The sample set of 120 consisted of all of the cores from the two middle scoring categories (>1-5%, 24 cores, and >5-10%, 26 cores). 35 cores from both the lowest and highest scoring categories $0 . 1 \%$ and $> 1 0 \%$ ) were randomly selected from the cores in these categories, for a total of 120 cores.

TMAs were stained with the following reagents according to the procedure outlined in the table below: Antigen retrieval buffer (citrate, $\tt p H 6 . 0 )$ : Dako cat. No. S1699; p53: Clone DO7 (Dako cat. No. M7001); Antibody diluent, Dako cat. No. S0809; LSAB $^ { + }$ detection kit (Dako cat. No. K0690); DAB, (Dako cat. No. K3468).

Table: p53 Staining Procedure   

<table><tr><td rowspan=1 colspan=1>Antigen retrieval with S1699 citratebuffer, pH 6.0</td><td rowspan=1 colspan=1>20-25 min</td></tr><tr><td rowspan=1 colspan=1>Antibody dilution using S0809</td><td rowspan=1 colspan=1>1:50</td></tr><tr><td rowspan=1 colspan=1>Antibody incubation</td><td rowspan=1 colspan=1>30 min at RT</td></tr><tr><td rowspan=1 colspan=1>Link incubation with biotinylatedanti-rabbit, anti-mouse and anti-goatimmunoglobulins</td><td rowspan=1 colspan=1>15 min incubation at RT</td></tr><tr><td rowspan=1 colspan=1>Streptavidin-Peroxidase incubation</td><td rowspan=1 colspan=1>15 min incubation at RT</td></tr><tr><td rowspan=1 colspan=1>DAB</td><td rowspan=1 colspan=1>5 min</td></tr><tr><td rowspan=1 colspan=1>Hematoxylin</td><td rowspan=1 colspan=1>15 sec</td></tr></table>

# Test Samples for Ki-67 Study:

Samples were sourced from a single research center, Ohio State University Medical Center (OSU), under IRB oversight and approval. 188 unique archived de-identified invasive breast carcinoma tissue specimens were used to create five TMAs. Sections of the TMAs were stained for Ki67 by OSU. Individual TMA cores measured 2 mm in diameter, with the total area of tissue for evaluation in each core equivalent to 16 high-power fields of view (400X magnification). The TMA slide set was scored by a qualified pathologist from Biolmagene, at which time TMA cores with insufficient tissue/tumor for evaluation and/or artifacts that obscured tissue assessment were excluded. The remainder of the cores (168) were placed into one of four positivity categories: 0-1% (15), >1-5% (29), >5-10% (35) and >10% (89).

The study sample set utilized 120 total TMA cores spanning a range of positivity from 0 to 100%. The sample set of 120 consisted of all of the cores from the three lower scoring categories (0-1%, >1-5%, and >5-10%) and 41 cores from the highest scoring category (>10%), which were randomly selected from the 89 cores in this category. At least 29 samples were included from all of the positivity categories with the exception of the 0-1% category. Because Ki67 is a proliferation marker and proliferation rates in breast cancer specimens are typically greater than zero, a smaller number of samples (15) from the 0-1% category were present in the TMA slide set, all of which were included in the study.

TMAs were stained with the following reagents according to the procedure outlined in the table below: Antigen retrieval buffer (citrate, pH 6.0): Dako cat. No. S1699; Ki-67: Clone

MIB1 (Dako cat. No. M7240); LSAB $^ { 1 + }$ detection kit (Dako cat. No. K0679); DAB, (Dako cat. No. K3468).

Table: Ki67 Staining Procedure   

<table><tr><td rowspan=1 colspan=1>Antigen retrieval</td><td rowspan=1 colspan=1>20-25 min</td></tr><tr><td rowspan=1 colspan=1>Antibody dilution</td><td rowspan=1 colspan=1>1:150</td></tr><tr><td rowspan=1 colspan=1>Antibody incubation</td><td rowspan=1 colspan=1>30-60 min at RT</td></tr><tr><td rowspan=1 colspan=1>Link incubation</td><td rowspan=1 colspan=1>15 min incubation at RT</td></tr><tr><td rowspan=1 colspan=1>Streptavidin-Peroxidaseincubation</td><td rowspan=1 colspan=1>15 min incubation at RT</td></tr><tr><td rowspan=1 colspan=1>DAB</td><td rowspan=1 colspan=1>5 min</td></tr><tr><td rowspan=1 colspan=1>Hematoxylin</td><td rowspan=1 colspan=1>15 sec</td></tr></table>

# Evaluations:

Comparative Study with Manual Microscopy:

For the comparative assessment, samples were scored by each investigator manually. After a minimum of one week had passed, the investigators scored the cases again using the PATHIAM system. Scoring was semi-quantitative using four percent positivity categories of $0 . 1 \%$ , ${ > } 1 { - } 5 \%$ , ${ > } 5 { - } 1 0 \%$ , and ${ \tt s } 1 0 \%$ . PATHIAM quantitative scores were also recorded.

# Reproducibility:

The PATHIAM scores from the equivalence assessment were also used to assess InterPathologist reproducibility.

One of the investigators for both p53 and Ki-67 (Dr. Goldstein) scored a subset of 20 cases on the PATHIAM system two additional times for the assessment of intra-reader reproducibility. A minimum of three days' washout occurred between PATHIAM scoring sessions. Additionally, the order the slides were reviewed was randomized between each scoring session.

# Analytical Specificity:

The specificity of the test results is dependent on the analytical performance of the immunohistochemical staining of the tissue.

# Assay Cut Off:

Clinical cut-offs used for the assessment of p53 & Ki67 varies between laboratories. The performance of the PATHIAM system was evaluated at three commonly used clinical cut-offs: $> 1 \% > 5 \%$ and ${ > } 1 0 \%$ .

# Data Collection, Data Entry, Data Verification, and Query Resolution:

# Data Collection

Participating pathologists captured the scoring data on Scoring Case Report Forms. They either entered the data directly onto the forms or dictated the results to a recorder. In all cases, the investigators reviewed the data on the form and signed each page.

# Data Entry Verification

Once all data entry was completed, data QC was performed. A single individual or a two person team performed data QC. When a Two Person team was available, Person 1 read the data from the original CRF while person 2 verified the data on the spreadsheet.

Corrections to the data were made as needed. Comments were entered describing any changes made. The spreadsheet was designated QC in the title, and the date of the QC noted in the header of each page.

# Query Resolution

Query resolution can arise from the data analysis process. Queries were sent to the investigative center in written fax or e-mail form. Corrections were made on the query resolution form, which was signed by the investigator. The forms were faxed or e-mailed back to the study coordinator, with the original also forwarded to the study coordinator. A copy was retained on site. Changes to the excel spreadsheet were noted as comments on the QC version of the file. When query resolution was complete, the final excel spreadsheet was saved as "Final". The final spreadsheets were used for the data analyses used to generate reports for regulatory submissions.

# PATHIAM System Traceability

One PATHIAM System was used for this comparison study (to accommodate different study sites, two monitors were used). The details of the system are as follows:

<table><tr><td rowspan=1 colspan=1>Computer</td><td rowspan=1 colspan=1>Lenovo ThinkPad T-series 6460EGU</td><td rowspan=1 colspan=1>S/N: L3-R5511 08/09</td></tr><tr><td rowspan=1 colspan=1>BROWSER</td><td rowspan=1 colspan=1>Internet Exp 7 Version 7.0.5730.11</td><td rowspan=1 colspan=1>n/a</td></tr><tr><td rowspan=1 colspan=1>Monitor 1</td><td rowspan=1 colspan=1>Dell 2407WFPB</td><td rowspan=1 colspan=1>S/N: MX-OGM504-T4262-7BL-2765</td></tr><tr><td rowspan=1 colspan=1>Monitor 2</td><td rowspan=1 colspan=1>Dell 2407WFP8</td><td rowspan=1 colspan=1>SN: MX-0G283H-74262-92C-35LS</td></tr><tr><td rowspan=1 colspan=1>PATHIAM Software</td><td rowspan=1 colspan=1>PS-000617 Rev. A (V 3.1)</td><td rowspan=1 colspan=1>n/a</td></tr><tr><td rowspan=1 colspan=1>iScan - ScannerSoftware</td><td rowspan=1 colspan=1>PS-000322 Rev. Q (V 2.1.0.2)</td><td rowspan=1 colspan=1>S/N: BI08N0059</td></tr></table>

# Data Analysis

Data was analyzed for the comparative performance of manual versus PATHIAMassisted scoring of Ki67 & p53, and for inter-reader and intra-reader reproducibility of the PATHIAM-assisted method of scoring.

Concordance ranges are presented in tables along with upper and lower $95 \%$ confidence interval ranges. Concordance calculations were determined by dividing the total number of cases with matching scores ("true" positives and negatives) by the total number of cases scored.

p53 Data Analysis and Tables Table 18: Concordance Results for p53 Scoring   

<table><tr><td rowspan=1 colspan=1>p53 Cut-OffThreshold</td><td rowspan=1 colspan=1>Manual vs PATHIAM-assistedSubstantial EquivalenceConcordance Range for 3Pathologists</td><td rowspan=1 colspan=1>PATHIAM-assisted vsPATHIAM-assistedReproducibilityConcordance Range for3 Pathologists</td><td rowspan=1 colspan=1>Manual vs ManualReproducibilityConcordance Range for3 Pathologists</td></tr><tr><td rowspan=1 colspan=1>&gt;1%</td><td rowspan=1 colspan=1>82% - 90%</td><td rowspan=1 colspan=1>88% - 93%</td><td rowspan=1 colspan=1>78% - 95%</td></tr><tr><td rowspan=1 colspan=1>&gt;5%</td><td rowspan=1 colspan=1>77% - 85%</td><td rowspan=1 colspan=1>90% - 93%</td><td rowspan=1 colspan=1>78% - 88%</td></tr><tr><td rowspan=1 colspan=1>&gt;10%</td><td rowspan=1 colspan=1>83% - 89%</td><td rowspan=1 colspan=1>93% - 97%</td><td rowspan=1 colspan=1>86% - 90%</td></tr></table>

Table 19: Concordance Results for p53 Scoring $\mathbf { \sigma }$ Exact $95 \%$ Upper Confidence Limits   

<table><tr><td rowspan=1 colspan=1>p53 Cut-OffThreshold</td><td rowspan=1 colspan=1>Manual vs PATHIAM-assistedSubstantial EquivalenceConcordance Range for 3Pathologists</td><td rowspan=1 colspan=1>PATHIAM-assisted vsPATHIAM-assistedReproducibilityConcordance Range for3 Pathologists</td><td rowspan=1 colspan=1>Manual vs ManualReproducibilityConcordance Range for3 Pathologists</td></tr><tr><td rowspan=1 colspan=1>&gt;1%</td><td rowspan=1 colspan=1>88% - 95%</td><td rowspan=1 colspan=1>93% · 97%</td><td rowspan=1 colspan=1>85% - 98%</td></tr><tr><td rowspan=1 colspan=1>&gt;5%</td><td rowspan=1 colspan=1>84% - 91%</td><td rowspan=1 colspan=1>95% - 97%</td><td rowspan=1 colspan=1>85% - 93%</td></tr><tr><td rowspan=1 colspan=1>&gt;10%</td><td rowspan=1 colspan=1>89% - 94%</td><td rowspan=1 colspan=1>97% - 99%</td><td rowspan=1 colspan=1>92% - 95%</td></tr></table>

Table 20: Concordance Results for p53 Scoring - Exact $95 \%$ Lower Confidence Limits   

<table><tr><td rowspan=1 colspan=1>p53 Cut-OffThreshold</td><td rowspan=1 colspan=1>Manual vs PATHIAM-assistedSubstantial EquivalenceConcordance Range for 3Pathologists</td><td rowspan=1 colspan=1>PATHIAM-assisted vsPATHIAM-assistedReproducibilityConcordance Range for3 Pathologists</td><td rowspan=1 colspan=1>Manual vs ManualReproducibilityConcordance Range for3 Pathologists</td></tr><tr><td rowspan=1 colspan=1>&gt;1%</td><td rowspan=1 colspan=1>73% - 83%</td><td rowspan=1 colspan=1>81% -87%</td><td rowspan=1 colspan=1>69% - 89%</td></tr><tr><td rowspan=1 colspan=1>&gt;5%</td><td rowspan=1 colspan=1>69% - 77%</td><td rowspan=1 colspan=1>83% - 87%</td><td rowspan=1 colspan=1>70% - 80%</td></tr><tr><td rowspan=1 colspan=1>&gt;10%</td><td rowspan=1 colspan=1>75% - 82%</td><td rowspan=1 colspan=1>87% - 92%</td><td rowspan=1 colspan=1>78% - 83%</td></tr></table>

Table 21: Reproducibility Concordance for Intra-Pathologist Scoring of p53   

<table><tr><td rowspan=1 colspan=1>Cut-Off Threshold</td><td rowspan=1 colspan=1>PATHIAM-assisted vs. PATHIAM-assistedReproducibility Concordance for 3 ScoringEvents</td></tr><tr><td rowspan=1 colspan=1>&gt;1%</td><td rowspan=1 colspan=1>85%</td></tr><tr><td rowspan=1 colspan=1>&gt;5%</td><td rowspan=1 colspan=1>80%</td></tr><tr><td rowspan=1 colspan=1>&gt;10%</td><td rowspan=1 colspan=1>80%</td></tr></table>

Ki-67 Data Analysis & Tables:

Table 22: Concordance Results for Ki-67 Scoring   

<table><tr><td rowspan=1 colspan=1>Ki-67 Cut-OffThreshold</td><td rowspan=1 colspan=1>Manual vs. PATHIAM-assisted SubstantialEquivalenceConcordance Range for3 Pathologists</td><td rowspan=1 colspan=1>PATHIAM-assisted vs.PATHIAM-assistedReproducibilityConcordance Range for3 Pathologists</td><td rowspan=1 colspan=1>Manual vs. ManualReproducibilityConcordance Range for3 Pathologists</td></tr><tr><td rowspan=1 colspan=1>&gt;1%</td><td rowspan=1 colspan=1>88%-93%</td><td rowspan=1 colspan=1>92%-94%</td><td rowspan=1 colspan=1>86%-91%</td></tr><tr><td rowspan=1 colspan=1>&gt;5%</td><td rowspan=1 colspan=1>87%-93%</td><td rowspan=1 colspan=1>90%-93%</td><td rowspan=1 colspan=1>85%-89%</td></tr><tr><td rowspan=1 colspan=1>&gt;10%</td><td rowspan=1 colspan=1>81%-89%</td><td rowspan=1 colspan=1>88-95%</td><td rowspan=1 colspan=1>80%-91%</td></tr></table>

Table 23: Concordance Results for Ki-67 Scoring - Exact $95 \%$ Upper Confidence Limits   
Table 24: Concordance Results for Ki-67 Scoring Exact $95 \%$ Lower Confidence Limits   

<table><tr><td rowspan=1 colspan=1>Ki-67 Cut-OffThreshold</td><td rowspan=1 colspan=1>Manual vs. PATHIAM-assisted SubstantialEquivalenceConcordance Range for3 Pathologists</td><td rowspan=1 colspan=1>PATHIAM-assisted vs.PATHIAM-assistedReproducibilityConcordance Range for3 Pathologists</td><td rowspan=1 colspan=1>Manual vs. ManualReproducibilityConcordance Range for3 Pathologists</td></tr><tr><td rowspan=1 colspan=1>&gt;1%</td><td rowspan=1 colspan=1>93%-97%</td><td rowspan=1 colspan=1>96%-98%</td><td rowspan=1 colspan=1>92%-95%</td></tr><tr><td rowspan=1 colspan=1>&gt;5%</td><td rowspan=1 colspan=1>92%-97%</td><td rowspan=1 colspan=1>95%-97%</td><td rowspan=1 colspan=1>91%-94%</td></tr><tr><td rowspan=1 colspan=1>&gt;10%</td><td rowspan=1 colspan=1>87%-94%</td><td rowspan=1 colspan=1>93%-98%</td><td rowspan=1 colspan=1>87%-95%</td></tr></table>

Table 25: Reproducibility Concordance for Intra-Pathologist Scoring of Ki-67   

<table><tr><td rowspan=1 colspan=1>Ki-67 Cut-OffThreshold</td><td rowspan=1 colspan=1>Manual vs PATHIAM-assisted SubstantialEquivalenceConcordance Range for3 Pathologists</td><td rowspan=1 colspan=1>PATHIAM-assisted vsPATHIAM-assistedReproducibilityConcordance Range for3 Pathologists</td><td rowspan=1 colspan=1>Manual vs ManualReproducibilityConcordance Range for3 Pathologists</td></tr><tr><td rowspan=1 colspan=1>&gt;1%</td><td rowspan=1 colspan=1>81%-87%</td><td rowspan=1 colspan=1>85%-88%</td><td rowspan=1 colspan=1>78%-84%</td></tr><tr><td rowspan=1 colspan=1>&gt;5%</td><td rowspan=1 colspan=1>79%-86%</td><td rowspan=1 colspan=1>83%-87%</td><td rowspan=1 colspan=1>77%-82%</td></tr><tr><td rowspan=1 colspan=1>&gt;10%</td><td rowspan=1 colspan=1>73%-82%</td><td rowspan=1 colspan=1>80%-89%</td><td rowspan=1 colspan=1>72%-84%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Cut Off Threshold</td><td rowspan=1 colspan=1>PATHIAM-assisted vs. PATHIAM-assistedReproducibility Concordance for 3 ScoringEvents</td></tr><tr><td rowspan=1 colspan=1>&gt;1%</td><td rowspan=1 colspan=1>80%</td></tr><tr><td rowspan=1 colspan=1>&gt;5%</td><td rowspan=1 colspan=1>85%</td></tr><tr><td rowspan=1 colspan=1>&gt;10%</td><td rowspan=1 colspan=1>85%</td></tr></table>

Treatment of Samples Rejected for Quality by the PATHIAM system: No cases were rejected.

# End Points:

Concordance was examined at three clinically accepted standards/cut-offs for positivity, $> 1 \% > 5 \%$ , and ${ \tt > } 1 0 \%$ , similar to the predicates.

# Conclusion:

The criterion of ≥75% concordance between manual microscopy and PATHIAM assisted scoring for the evaluation of p53 & Ki67 was met by all three pathologists for all three clinical cut-offs evaluated.

Inter-pathologist reproducibility for three pathologists using the PATHIAM system also exceeded 75% concordance at all three clinical cut-offs. Inter-Pathologist reproducibility using the PATHIAM system was higher than Inter-Pathologist reproducibility using manual microscopy at all three clinical cut-offs, indicating that PATHIAM assisted scoring is more consistent than manual microscopy.

Intra-pathologist reproducibility for 3 scoring sessions using the PATHIAM system exceeded 75% concordance at all three clinical cut-offs.

# Step by Step Scoring Procedure

# Manual Scoring

Overview: the pathologist manually scores test samples in tissue microarrays on glass slides under the microscope.

Materials required:

• Sample slides   
• TMA maps Color pictures of samples taken at low magnification to help pathologist locate specific core on glass slide Scoring Case Report Forms

Materials required but not provided:

Microscope

Step-by-Step Protocol:

Have pathologist review the training tissue samples for each scoring group $( 0 . 1 \%$ , ${ > } 1 { - } 5 \%$ , ${ > } 5 { - } 1 0 \%$ , ${ \tt > } 1 0 \% \mathrm { ~ , ~ }$   
2. Give pathologist the randomly ordered list of test samples to be scored along with the TMA map, the corresponding TMA slide, and the low power print out corresponding to the first test sample.   
3. Pathologist will locate the correct test sample under the microscope using the TMA map and the low power image of the test sample.   
4. Pathologist will then review the entire test sample under the microscope as he/she would review other histopathology specimens using various objectives and freely moving the slide to evaluate multiple fields of view to arrive at a score.   
5. Pathologist will record score on the provided scoring case report form for each test sample following the review of that test sample.   
6. Pathologist will repeat the process for all 120 test samples.   
7. Pathologist will review and sign the scoring case report form at the end of the scoring session.

# PATHIAM Assisted Scoring

Overview: the pathologist will navigate the test sample images and select the field of view (at least two per test sample) on the monitor. After selecting each FOV, the pathologist will click on the "analyze" button. The pathologist will then be presented with the score for that FOV, as well as the aggregate score for all analyzed FOVs. The pathologist will have the ability to accept or reject scores for individual FOVs as well as the aggregate score. After selecting and analyzing at least two FOVs, the pathologist will select an appropriate scoring category for the sample on the case report form (which may or may not correspond to the PATHIAM aggregated score). The pathologist will also record the PATHIAM aggregated raw score for each sample.

Materials required:

• PATHIAM installed on computer   
• Monitor Mouse, keyboard TMA maps Color pictures of samples taken at low magnification to help pathologist locate specific core on digitized slides Scoring Case Report Forms

Materials required but not provided: none

Step-by-Step Protocol:

Pathologist will open PATHIAM and login using the provided username and password.

2Pathologist will open the case list and select case number corresponding to the first test sample on the case report form.

3.Pathologist will open the digital image and navigate to the first test sample using the TMA map. The test sample to be scored in each image will be outlined by a red box. Pathologist will select at least two fields of view (FOV) containing representative areas of the tumor for scoring. After selecting each FOV, the pathologist will click on the "analyze" button. The pathologist will then be presented with the score for that FOV, as well as the aggregate score for all analyzed FOVs. The pathologist will have the ability to accept or reject scores for individual FOVs as well as the aggregate score. After selecting and analyzing at least two FOVs, the pathologist will select an appropriate scoring category for the sample on the case report form (which may or may not correspond to the PATHIAM aggregated score). The pathologist will also record the PATHIAM aggregated raw score for each sample.

4. Pathologist will repeat the process for all 120 test samples.

Pathologist will review and sign the scoring case report form at the end of the scoring session.

# PATHIAM System Precision/Reproducibility Studies (intra and inter system)

Title: Intersystem and intra-system performance of the PATHIAM System for analysis of Ki-67 & p53 nuclear protein immunohistochemistry in breast carcinoma tissue.

# Objective:

The objectives for this study are to understand the intra system and inter system performance characteristics of the PATHIAM System for p53 and Ki-67 stained breast carcinoma tissue slides.

Sample Procurement Center:   
Ohio State University Medical Center   
310 Doan Hall, 410 West $1 0 ^ { \mathfrak { d } }$ Av, Columbus, OH   
CLIA # 36D1046162

Investigators and Study Sites: The PATHIAM system study was performed at Biolmagene under the supervision of Dr. Robert Monroe, Chief Medical Officer of BioImagene.

References: TP-000048 & TP-000049 Pathiam System Study Protocols for p53 & Ki-67 (breast), inter system and intra system studies.

# Device Description:

The PATHIAMTM System is an instrument and software system designed to assist the qualified pathologist in the consistent quantitative assessment of protein expression in immunohistochemically stained histologic sections from formalin-fixed, paraffinembedded normal and neoplastic tissues. The system consists of a slide scanner (iScan), computer, monitor, keyboard, mouse, image analysis algorithms for specific immunohistochemical markers, and software with a Windows web browser-based user interface. PATHIAM is a web-based, end-to-end digital pathology software solution that allows pathology labs to acquire, manage, view, analyze, share, and report on digital images of pathology specimens. Using the PATHIAM software, the pathologist can view digital images, add annotations, make measurements, perform image analysis, and generate reports.

# Volume 1 Page 47

# Study Design

The intra system (PATHIAM system with iScan) study was performed on five sets of images (one set $\simeq$ eight test samples) produced by one scanner and scored on one computer system (consisting of a computer, monitor, keyboard, p53 & Ki-67 image analysis algorithms, MS Windows web browser and a mouse). Pre-selected field of views (8) from TMA cores randomly selected by a qualified pathologist from the four scoring categories were used for this study. Pre-selection of FOVs was necessary to allow the study scientist to locate corresponding FOVs on the multiple digital images generated by the same scanner for scoring. The goal of the inter system study was to assess the consistency and reproducibility of the PATHIAM system (no pathologist) for p53 & Ki-67 scoring on different systems.

This study was repeated on a total of three different scanners and computer systems. The same pre-selected field of views used for the inter system studies were also used for intra system study.

The test sample selection process for the system studies was as follows:   
- 120 de-identified test samples were selected for the clinical studies (from the   
comparison studies above for $\mathsf { p } 5 3$ and Ki-67)   
- These 120 test samples were designated by the TMA number and the core position. - The core position was assigned on the basis of the row (labeled as A-E) and the column (numbered from 1-9)   
- Semi-quantitative scores $( 0 { - } 1 \% , > 1 { - } 5 \%$ , ${ > } 5 { - } 1 0 \%$ , and ${ \tt > } 1 0 \%$ ) based on prior manual microscopic review by a qualified pathologist were available for the 120 test samples - The TMA slides containing the 120 test samples were digitized by the iScan/PATHIAM system described in detail in the report   
- The digitized TMA slides/images were uploaded into the PATHIAM software   
- Five test samples from each scoring category $( 0 { - } 1 \% , > 1 { - } 5 \% , > 5 { - } 1 0 \%$ , and ${ \tt > } 1 0 \%$ )were randomly selected for the intra pathologist reproducibility study being conducted in parallel   
- Two of five test samples from each scoring category (total of 8) from the intra   
pathologist reproducibility studies were then randomly selected for the intra and inter system studies   
- The digital images containing these 8 test samples were reviewed in the PATHIAM system by a qualified pathologist, with one Field of View (FOV) selected for each test sample   
- The selected FOVs from the eight cores represented the area used for image analysis for both intra- and inter-system studies

# Precision/Reproducibility Study results (intra and inter system)

Each test sample (8 of them) was scanned 5 times on one scanner. Each test sample (FOV) on each scan was scored by PATHIAM (raw score). The PATHIAM raw scores were used for data comparison analysis.

This was repeated on three different PATHIAM Systems (including one study from above) and scores are compared and presented in the tables below along with the PATHIAM System identification traceability information.

# P53 Data Analysis

Table 26: System Identification Traceability   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>SYSTEM I</td><td rowspan=1 colspan=1>SYSTEM II</td><td rowspan=1 colspan=1>SYSTEM III</td></tr><tr><td rowspan=1 colspan=1>Computer #Details</td><td rowspan=1 colspan=1>DELL PRECISION 5400INTEL XEON CPUe5410 S/N 6XBQBTH1</td><td rowspan=1 colspan=1>DELL PRECISION 5400INTEL XEON cpue5410 S/N 9G90PJ</td><td rowspan=1 colspan=1>DELL PRECISION 5400INTEL XEON cpue5410 S/N DMYWHHI</td></tr><tr><td rowspan=1 colspan=1>Monitor # Details</td><td rowspan=1 colspan=1>DELL 24&quot; HIGHRESOLUTION LCD S/N262 923 1955</td><td rowspan=1 colspan=1>DELL 24&quot; HIGHRESOLUTION LCD S/N262 930 ID35</td><td rowspan=1 colspan=1>DELL 24&quot; HIGHRESOLUTION LCD S/N262 84F 1FOS</td></tr><tr><td rowspan=1 colspan=1>Scanner # Details</td><td rowspan=1 colspan=1>BIOIMAGENE ISCAN2.1.0.2 (PS-000322)S/N BIO8N0071</td><td rowspan=1 colspan=1>BIOIMAGENE ISCAN2.1.0.2 (PS-000322)S/N B108N0089</td><td rowspan=1 colspan=1>BIOIMAGENE ISCAN2.1.0.2 (PS-000322)S/N BIO8N0051</td></tr><tr><td rowspan=1 colspan=1>Mouse</td><td rowspan=1 colspan=1>DELL DPIN OXN 96710401GUS</td><td rowspan=1 colspan=1>DELL DPIN OXN 96710401GUS</td><td rowspan=1 colspan=1>DELL DPIN OXN 96710401GUS</td></tr><tr><td rowspan=1 colspan=1>Pathiam Software</td><td rowspan=1 colspan=1>Version 3.1,MS Browser 6.0.29</td><td rowspan=1 colspan=1>Version 3.1,MS Browser 6.0.29</td><td rowspan=1 colspan=1>Version 3.1,MS Browser 6.0.29</td></tr><tr><td rowspan=1 colspan=1>Keyboard</td><td rowspan=1 colspan=1>DELL SK8115 E145614</td><td rowspan=1 colspan=1>DELL SK8115 E145614</td><td rowspan=1 colspan=1>DELL SK811S E145614</td></tr></table>

Table 27:p53 System Precision Study SYSTEM I (intra system)   

<table><tr><td rowspan=1 colspan=1>Line Item #</td><td rowspan=1 colspan=1>SampleID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>A7</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>:</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>:</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>C9</td><td rowspan=1 colspan=1>42.90</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.06</td></tr><tr><td rowspan=1 colspan=1>TMA 4 2007</td><td rowspan=1 colspan=1>B5</td><td rowspan=1 colspan=1>2.82</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>2.67</td></tr><tr><td rowspan=1 colspan=1>TMA 5 2007</td><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>73.50</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.07</td></tr><tr><td rowspan=1 colspan=1>TMA 1 2007</td><td rowspan=1 colspan=1>B9</td><td rowspan=1 colspan=1>16.44</td><td rowspan=1 colspan=1>0.01</td><td rowspan=1 colspan=1>0.09</td></tr><tr><td rowspan=1 colspan=1>TMA 4 2007</td><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>22.14</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>0.32</td></tr><tr><td rowspan=1 colspan=1>TMA 4 2007</td><td rowspan=1 colspan=1>B3</td><td rowspan=1 colspan=1>24.05</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.23</td></tr></table>

T008g 41 I ws 1

# Table 28: p53 System Precision Study SYSTEM II (intra system)

Table 29: p53 System Precision Study SYSTEM III (intra system)   

<table><tr><td rowspan=1 colspan=1>Line Item #</td><td rowspan=1 colspan=1>SampleID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>A7</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>.</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>.</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>C9</td><td rowspan=1 colspan=1>42.74</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.05•</td></tr><tr><td rowspan=1 colspan=1>TMA 4 2007</td><td rowspan=1 colspan=1>B5</td><td rowspan=1 colspan=1>2.57</td><td rowspan=1 colspan=1>0.01</td><td rowspan=1 colspan=1>0.58</td></tr><tr><td rowspan=1 colspan=1>TMA 5 2007</td><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>72.89</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.06</td></tr><tr><td rowspan=1 colspan=1>TMA 1 2007</td><td rowspan=1 colspan=1>B9</td><td rowspan=1 colspan=1>16.51</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.24</td></tr><tr><td rowspan=1 colspan=1>TMA 4 2007</td><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>22.44</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.17</td></tr><tr><td rowspan=1 colspan=1>TMA 4 2007</td><td rowspan=1 colspan=1>B3</td><td rowspan=1 colspan=1>22.68</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.25</td></tr></table>

(s=u) 6800N8018

(3-) 1Uo   

<table><tr><td rowspan=1 colspan=1>Line Item #</td><td rowspan=1 colspan=1>Sample ID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>A7</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>:</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>b</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>C9</td><td rowspan=1 colspan=1>42.60</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.11</td></tr><tr><td rowspan=1 colspan=1>TMA 4 2007</td><td rowspan=1 colspan=1>B5</td><td rowspan=1 colspan=1>2.71</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.78</td></tr><tr><td rowspan=1 colspan=1>TMA S 2007</td><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>74.07</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>0.18</td></tr><tr><td rowspan=1 colspan=1>TMA 1 2007</td><td rowspan=1 colspan=1>B9</td><td rowspan=1 colspan=1>16.49</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.18</td></tr><tr><td rowspan=1 colspan=1>TMA 4 2007</td><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>24.42</td><td rowspan=1 colspan=1>0.01</td><td rowspan=1 colspan=1>0.05</td></tr><tr><td rowspan=1 colspan=1>TMA 4 2007</td><td rowspan=1 colspan=1>B3</td><td rowspan=1 colspan=1>24.90</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>0.40</td></tr></table>

Table 30: p53 Inter-system Reproducibility Study - Results from System I I, III above   
(J"c--)   

<table><tr><td rowspan=1 colspan=1>LineItem #</td><td rowspan=1 colspan=1>SampleID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>A7</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>0.00 .</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>.TMA 32007</td><td rowspan=1 colspan=1>C9</td><td rowspan=1 colspan=1>42.75</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>0.30</td></tr><tr><td rowspan=1 colspan=1>TMA 42007</td><td rowspan=1 colspan=1>B5</td><td rowspan=1 colspan=1>2.70</td><td rowspan=1 colspan=1>0.12</td><td rowspan=1 colspan=1>4.32</td></tr><tr><td rowspan=1 colspan=1>TMA S2007</td><td rowspan=1 colspan=1>E3</td><td rowspan=1 colspan=1>73.49</td><td rowspan=1 colspan=1>0.50</td><td rowspan=1 colspan=1>0.68</td></tr><tr><td rowspan=1 colspan=1>TMA 12007</td><td rowspan=1 colspan=1>B9</td><td rowspan=1 colspan=1>16.48</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.25</td></tr><tr><td rowspan=1 colspan=1>TMA 42007</td><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>23.00</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=1>4.55</td></tr><tr><td rowspan=1 colspan=1>TMA 42007</td><td rowspan=1 colspan=1>B3</td><td rowspan=1 colspan=1>23.88</td><td rowspan=1 colspan=1>0.95</td><td rowspan=1 colspan=1>3.97</td></tr></table>

# Ki-67 Data Analysis

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>SYSTEM I</td><td rowspan=1 colspan=1>SYSTEM II</td><td rowspan=1 colspan=1>SYSTEM III</td></tr><tr><td rowspan=1 colspan=1>Computer #Details</td><td rowspan=1 colspan=1>DELL PRECISION 5400INTEL XEON cpue5410 S/N 6XBQBTH1</td><td rowspan=1 colspan=1>DELL PRECISION 5400INTEL XEON cpue5410 S/N 9G90PJ</td><td rowspan=1 colspan=1>DELL PRECISION 5400INTEL XEON cpue5410 S/N DMYWHHI</td></tr><tr><td rowspan=1 colspan=1>Monitor # Details</td><td rowspan=1 colspan=1>DELL 24&quot; HIGHRESOLUTION LCD S/N262 923 195S</td><td rowspan=1 colspan=1>DELL 24&quot; HIGHRESOLUTION LCD S/N262 930 ID35</td><td rowspan=1 colspan=1>DELL 24&quot; HIGHRESOLUTION LCD S/N262 84F 1FOS</td></tr><tr><td rowspan=1 colspan=1>Scanner # Details</td><td rowspan=1 colspan=1>BIOIMAGENE ISCAN2.1.0.2 (PS-000322)S/N BIO8N0071</td><td rowspan=1 colspan=1>BIOIMAGENE ISCAN2.1.0.2 (PS-000322)S/N BI08N0089</td><td rowspan=1 colspan=1>BIOIMAGENE ISCAN2.1.0.2 (PS-000322)S/N BIO8N0051</td></tr><tr><td rowspan=1 colspan=1>Mouse</td><td rowspan=1 colspan=1>DELL DPIN OXN 96710401GUS</td><td rowspan=1 colspan=1>DELL DPIN OXN 96710401GUS</td><td rowspan=1 colspan=1>DELL DPIN OXN 96710401GUS</td></tr><tr><td rowspan=1 colspan=1>Pathiam Software</td><td rowspan=1 colspan=1>Version 3.1,MS Browser 6.0.29</td><td rowspan=1 colspan=1>Version 3.1,MS Browser 6.0.29</td><td rowspan=1 colspan=1>Version 3.1,MS Browser 6.0.29</td></tr><tr><td rowspan=1 colspan=1>Keyboard</td><td rowspan=1 colspan=1>DELL SK8115 E145614</td><td rowspan=1 colspan=1>DELL SK8115 E145614</td><td rowspan=1 colspan=1>DELL SK8115 E145614</td></tr></table>

Table 31: Ki-67 System Precision Study SYSTEM I (intra system)   

<table><tr><td rowspan=1 colspan=1>LineItem #</td><td rowspan=1 colspan=1>SampleID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>A2</td><td rowspan=1 colspan=1>31.78</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>0.31</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E2</td><td rowspan=1 colspan=1>64.53</td><td rowspan=1 colspan=1>0.25</td><td rowspan=1 colspan=1>0.39.</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>A3</td><td rowspan=1 colspan=1>15.45</td><td rowspan=1 colspan=1>0.15</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TMA 42007</td><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>17.82</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.50</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E7</td><td rowspan=1 colspan=1>9.76</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.22</td></tr><tr><td rowspan=1 colspan=1>TMA 52007</td><td rowspan=1 colspan=1>D6</td><td rowspan=1 colspan=1>4.85</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.40</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E5</td><td rowspan=1 colspan=1>9.13</td><td rowspan=1 colspan=1>0.12</td><td rowspan=1 colspan=1>1.35</td></tr><tr><td rowspan=1 colspan=1>TMA 22007</td><td rowspan=1 colspan=1>A1</td><td rowspan=1 colspan=1>0.88</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>1.78</td></tr></table>

(S=u) T∠00N8018

Table 32:Ki-67 System Precision Study SYSTEM Π (intra system)   

<table><tr><td rowspan=1 colspan=1>Line Item #</td><td rowspan=1 colspan=1>Sample ID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>A2</td><td rowspan=1 colspan=1>32.77</td><td rowspan=1 colspan=1>0.37</td><td rowspan=1 colspan=1>1.13</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>E2</td><td rowspan=1 colspan=1>63.29</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>0.12</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>A3</td><td rowspan=1 colspan=1>15.76</td><td rowspan=1 colspan=1>0.17</td><td rowspan=1 colspan=1>1.09</td></tr><tr><td rowspan=1 colspan=1>TMA 4 2007</td><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>17.91</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.23</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>E7</td><td rowspan=1 colspan=1>9.41</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.44</td></tr><tr><td rowspan=1 colspan=1>TMA 5 2007</td><td rowspan=1 colspan=1>D6</td><td rowspan=1 colspan=1>4.87</td><td rowspan=1 colspan=1>0.14</td><td rowspan=1 colspan=1>2.90</td></tr><tr><td rowspan=1 colspan=1>TMA 3 2007</td><td rowspan=1 colspan=1>E5</td><td rowspan=1 colspan=1>9.27</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.42</td></tr><tr><td rowspan=1 colspan=1>TMA 2 2007</td><td rowspan=1 colspan=1>A1</td><td rowspan=1 colspan=1>0.85</td><td rowspan=1 colspan=1>0.01</td><td rowspan=1 colspan=1>0.89</td></tr></table>

(S=u) 6800N8018

Table 33: Ki-67 System Precision Study SYSTEM III (intra system)   

<table><tr><td rowspan=1 colspan=1>Line Item#</td><td rowspan=1 colspan=1>Sample ID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>A2</td><td rowspan=1 colspan=1>31.53</td><td rowspan=1 colspan=1>0.19</td><td rowspan=1 colspan=1>0.59</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E2</td><td rowspan=1 colspan=1>62.11</td><td rowspan=1 colspan=1>0.23</td><td rowspan=1 colspan=1>0.36</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>A3</td><td rowspan=1 colspan=1>15.05</td><td rowspan=1 colspan=1>0.12</td><td rowspan=1 colspan=1>0.78</td></tr><tr><td rowspan=1 colspan=1>TMA 42007</td><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>17.66</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.14</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E7</td><td rowspan=1 colspan=1>9.81</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>0.72</td></tr><tr><td rowspan=1 colspan=1>TMA 52007</td><td rowspan=1 colspan=1>D6</td><td rowspan=1 colspan=1>4.95</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.68</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E5</td><td rowspan=1 colspan=1>9.43</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.24</td></tr><tr><td rowspan=1 colspan=1>TMA 22007</td><td rowspan=1 colspan=1>A1</td><td rowspan=1 colspan=1>0.86</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.35</td></tr></table>

(S=u) TSO0N8018 E  A  aM

Table 34: Ki-67 Inter-system Reproducibility Study - Results from System I, II, III above   

<table><tr><td rowspan=1 colspan=1>LineItem #</td><td rowspan=1 colspan=1>SampleID</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>A2</td><td rowspan=1 colspan=1>32.03</td><td rowspan=1 colspan=1>0.60</td><td rowspan=1 colspan=1>1.87</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E2</td><td rowspan=1 colspan=1>63.31</td><td rowspan=1 colspan=1>1.04</td><td rowspan=1 colspan=1>1.65</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>A3</td><td rowspan=1 colspan=1>15.42</td><td rowspan=1 colspan=1>0.33</td><td rowspan=1 colspan=1>2.14</td></tr><tr><td rowspan=1 colspan=1>TMA 42007</td><td rowspan=1 colspan=1>D4</td><td rowspan=1 colspan=1>17.79</td><td rowspan=1 colspan=1>0.12 .</td><td rowspan=1 colspan=1>0.66</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E7</td><td rowspan=1 colspan=1>9.66</td><td rowspan=1 colspan=1>0.19</td><td rowspan=1 colspan=1>1.95</td></tr><tr><td rowspan=1 colspan=1>TMA 52007</td><td rowspan=1 colspan=1>D6</td><td rowspan=1 colspan=1>4.89</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>1.84</td></tr><tr><td rowspan=1 colspan=1>TMA 32007</td><td rowspan=1 colspan=1>E5</td><td rowspan=1 colspan=1>9.28</td><td rowspan=1 colspan=1>0.14</td><td rowspan=1 colspan=1>1.53</td></tr><tr><td rowspan=1 colspan=1>TMA 22007</td><td rowspan=1 colspan=1>A1</td><td rowspan=1 colspan=1>0.86</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>2.07</td></tr></table>

(Sε=) ε 'Z 't wa]sAs

# Discussion:

The field of view analyzed for each test sample was manually drawn with the drawing tool and is therefore not exactly the same for every image analyzed in the intra $\pmb { \& }$ inter system studies. The variability in the reproducibility results can therefore be mostly attributed to the slight variations in the composition of the fields of view in for each image analyzed.

# Conclusion:

The above tables for the intra- and inter-system studies confirm the precision and reproducibility of Ki-67 and p53 scoring within the same system and between different systems. The precision and reproducibility study data (averages, standard deviation and $\%$ CV) showed that PATHIAM System precision and reproducibility is similar to that of the predicate devices, and is therefore acceptable.

Bioimagene, Inc.   
c/o Mr. Indu P. Lakshman   
Director of Quality and Regulatory Affairs 919 Hermosa Court   
Sunnyvale, CA 94085

Re: k092333 Trade/Device Name: PATHIAM System with iScan for p53 and Ki67 Regulation Number: 21CFR§864.1860 Regulation Name: Immunohistochemistry reagents and kits Regulatory Class: Class II Product Code: NQN Dated: September 13, 2010 Received: September 15, 2010

Dear Mr. Lakshman:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of theFederal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or classIII (MA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical

device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucml15809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

ManaIn Chan

Maria M. Chan, Ph.D.   
Director   
Division of Immunology and Hematology Devices Office of In Vitro Diagnostic Device Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number: k092333

Device Name: PATHIAM™ System with iScan for p53 and Ki67

Indications For Use:

Device Name: iScan Slide Scanner

Intended Use This device is intended for in vitro diagnostic (IVD) use.

The PATHIAM System is intended as an aid to the pathologist to detect, count, and classify cells of clinical interest based on recognition of cellular objects of particular color, size, and shape, using appropriate controls to assure the validity of the scores.

This instrument is intended for in-vitro diagnostic use only with those assays for which it has eceived FDA clearance.

The iScan Slide Scanner System is designed to be used to scan and digitize microscope slides, and compress and view digitized images of microscope slides.

If the Scanner is used in any way not specified in this manual, the protection provided by the equipment may be compromised.

# Indications for Use

510(k) Number: k092333

Device Name: PATHIAM™ System with iScan for p53 and Ki67

Indications For Use:

Device Name: PATHIAM System with iScan for Ki-67

Intended Use This device is intended for in vitro diagnostic (IVD) use.

The PATHIAM System is intended as an aid to the pathologist to detect, count, and classify cells oclinical interest based on recognition of cellular objects of particular color, size, and shape, using appropriate controls to assure the validity of the scores.

The Ki-67 application is intended as an aid to the pathologist to quantify the percentage of positively stained nuclei in formalin-fixed paraffin embedded normal and neoplastic breast tissue specimens immunohistochemically stained with Dako mouse monoclonal anti-human Ki-67 antigen, clone MIB1 visualized with DAB chromogen as specified in the instructions for these reagents. It is the responsibility of a qualified pathologist to employ appropriate morphological studies and controls as specified in the instructions for Dako Ki-67 to assure the validity of the PATHIAM-assisted Ki-67 assessment.

# Indication For Use

Ki-67 results provided by the PATHIAM System are indicated for use to assess proliferative activity when used with in vitro diagnostic reagents marketed for this indication. Interpretation should be made within the context of the patient's clinical history and other diagnostic tests by a qualified pathologist. The pathologist must verify agreement with the PATHIAM score.

# Indications for Use

510(k) Number: k092333

Device Name: PATHIAM™ System with iScan for p53 and Ki67

Indications For Use:

Device Name: PATHIAM System with iScan for p53

Intended Use This device is intended for in vitro diagnostic (IVD) use.

The PATHIAM System is intended as an aid to the pathologist to detect, count, and classify cells of clinical interest based on recognition of cellular objects of particular color, size, and shape, using appropriate controls to assure the validity of the scores.

The p53 application is intended for use as an aid to the pathologist to quantify the percentage of positively stained nuclei in formalin fixed paraffin embedded breast tissue specimens stained with Dako mouse monoclonal anti-human p53 antibody, clone DO7and visualized with DAB. chromogen, to detect both wild-type and mutant p53, a nuclear protein, as specified in the instructions for these reagents. It is the responsibility of a qualified pathologist to employ appropriate morphological studies and controls as specified in the instructions for Dako p53 to assure the validity of the PATHIAM-assisted p53 assessment.

# Indication For Use

The p53 results provided by the PATHIAM System are indicated for use for the identification of p53 accumulation in human neoplasias when used with IVD reagents marketed for this indication. Interpretation should be made within the context of the patient's clinical history and other diagniostic tests by a qualified pathologist. The pathologist must verify agreement with the PATHIAM score.